EASL is pushing for EU policy development in areas relevant to liver disease, such as public health, research, communicable diseases (viral hepatitis), nutrition and obesity, alcohol, cancer, rare diseases, organ donation and transplantation to take liver disease into account.

For an outline of each policy area, how each is relevant to liver disease and how EASL has positioned itself in the debate, click on the hepatocytes below.

Learn more about our advocacy activities here.